From the Canadian Press:
B.C.'s cost controls on prescription drugs haven't affected the health of medical research investment in this province.
A University of British Columbia study finds the BC PharmaCare policy of refusing to pay for name-brand drugs when generic drugs offer equal results has had no effect on research investment.
The study, by the UBC Centre for Health Services and Policy Research, reveals pharmaceutical research and development has increased from $16 million in 1994 to $50 million in 2005. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment